Thyrsiferol Inhibits Mitochondrial Respiration and HIF-1 Activation

Area of Science:

• Marine natural products chemistry
• Cancer biology
• Cellular respiration

Background:

• Hypoxia-inducible factor-1 (HIF-1) is a key regulator of cellular adaptation to low oxygen conditions, often activated in tumors.
• Marine red algae are a source of unique bioactive compounds with potential therapeutic applications.
• Thyrsiferol is a cytotoxic metabolite isolated from marine red algae.

Purpose of the Study:

• To investigate the molecular mechanisms underlying the cytotoxic effects of thyrsiferol.
• To evaluate the potential of thyrsiferol as an inhibitor of HIF-1 activation in cancer cells.
• To determine the specific cellular targets of thyrsiferol.

Main Methods:

• Cell-based assays using T47D human breast tumor cells.
• Measurement of HIF-1 activation and target gene expression (VEGF, GLUT-1) via mRNA levels.
• Assessment of cell viability and proliferation.
• Mitochondrial respiration studies, specifically Complex I activity.

Main Results:

• Thyrsiferol inhibited hypoxia-induced HIF-1 activation by 66% at 3 microM in T47D cells.
• Compound 1 suppressed the hypoxic induction of HIF-1 target genes (VEGF, GLUT-1) at the mRNA level.
• Thyrsiferol exhibited selective, time-dependent inhibition of tumor cell viability and proliferation.
• Mechanistic studies revealed selective suppression of mitochondrial respiration at Complex I with an IC(50) of 3 microM.

Conclusions:

• Thyrsiferol is a structurally unique inhibitor of mitochondrial Complex I, exhibiting rotenone-like activity.
• The inhibition of HIF-1 activation and mitochondrial respiration likely contributes to thyrsiferol's observed cytotoxicity.
• Thyrsiferol represents a promising lead compound for anticancer drug development and may play a role in marine chemical defense.